229 related articles for article (PubMed ID: 34083726)
1. Novel lamprey antibody recognizes terminal sulfated galactose epitopes on mammalian glycoproteins.
McKitrick TR; Bernard SM; Noll AJ; Collins BC; Goth CK; McQuillan AM; Heimburg-Molinaro J; Herrin BR; Wilson IA; Cooper MD; Cummings RD
Commun Biol; 2021 Jun; 4(1):674. PubMed ID: 34083726
[TBL] [Abstract][Full Text] [Related]
2. Sialylated and sulfated N-Glycans in MDCK and engineered MDCK cells for influenza virus studies.
Byrd-Leotis L; Jia N; Matsumoto Y; Lu D; Kawaoka Y; Steinhauer DA; Cummings RD
Sci Rep; 2022 Jul; 12(1):12757. PubMed ID: 35882911
[TBL] [Abstract][Full Text] [Related]
3. Installation of O-glycan sulfation capacities in human HEK293 cells for display of sulfated mucins.
Sun L; Konstantinidi A; Ye Z; Nason R; Zhang Y; Büll C; Kahl-Knutson B; Hansen L; Leffler H; Vakhrushev SY; Yang Z; Clausen H; Narimatsu Y
J Biol Chem; 2022 Feb; 298(2):101382. PubMed ID: 34954141
[TBL] [Abstract][Full Text] [Related]
4. Molecular cloning and expression of a novel human beta-Gal-3-O-sulfotransferase that acts preferentially on N-acetyllactosamine in N- and O-glycans.
Suzuki A; Hiraoka N; Suzuki M; Angata K; Misra AK; McAuliffe J; Hindsgaul O; Fukuda M
J Biol Chem; 2001 Jun; 276(26):24388-95. PubMed ID: 11323440
[TBL] [Abstract][Full Text] [Related]
5. Glycoengineering of therapeutic glycoproteins: in vitro galactosylation and sialylation of glycoproteins with terminal N-acetylglucosamine and galactose residues.
Raju TS; Briggs JB; Chamow SM; Winkler ME; Jones AJ
Biochemistry; 2001 Jul; 40(30):8868-76. PubMed ID: 11467948
[TBL] [Abstract][Full Text] [Related]
6. Sulfation of O-glycans on Mucin-type Proteins From Serous Ovarian Epithelial Tumors.
Thomsson KA; Vitiazeva V; Mateoiu C; Jin C; Liu J; Holgersson J; Weijdegård B; Sundfeldt K; Karlsson NG
Mol Cell Proteomics; 2021; 20():100150. PubMed ID: 34555499
[TBL] [Abstract][Full Text] [Related]
7. Sialylated N-glycans in adult rat brain tissue--a widespread distribution of disialylated antennae in complex and hybrid structures.
Zamze S; Harvey DJ; Chen YJ; Guile GR; Dwek RA; Wing DR
Eur J Biochem; 1998 Nov; 258(1):243-70. PubMed ID: 9851715
[TBL] [Abstract][Full Text] [Related]
8. The enzymatic sulfation of glycoprotein carbohydrate units: blood group T-hapten specific and two other distinct Gal:3-O-sulfotransferases as evident from specificities and kinetics and the influence of sulfate and fucose residues occurring in the carbohydrate chain on C-3 sulfation of terminal Gal.
Chandrasekaran EV; Jain RK; Vig R; Matta KL
Glycobiology; 1997 Sep; 7(6):753-68. PubMed ID: 9376678
[TBL] [Abstract][Full Text] [Related]
9. Glycoproteomics enabled by tagging sialic acid- or galactose-terminated glycans.
Ramya TN; Weerapana E; Cravatt BF; Paulson JC
Glycobiology; 2013 Feb; 23(2):211-21. PubMed ID: 23070960
[TBL] [Abstract][Full Text] [Related]
10. Functional contributions of N- and O-glycans to L-selectin ligands in murine and human lymphoid organs.
Arata-Kawai H; Singer MS; Bistrup A; Zante Av; Wang YQ; Ito Y; Bao X; Hemmerich S; Fukuda M; Rosen SD
Am J Pathol; 2011 Jan; 178(1):423-33. PubMed ID: 21224079
[TBL] [Abstract][Full Text] [Related]
11. Molecular cloning and characterization of a novel human galactose 3-O-sulfotransferase that transfers sulfate to gal beta 1-->3galNAc residue in O-glycans.
Seko A; Hara-Kuge S; Yamashita K
J Biol Chem; 2001 Jul; 276(28):25697-704. PubMed ID: 11333265
[TBL] [Abstract][Full Text] [Related]
12. Dimeric galectin-1 binds with high affinity to alpha2,3-sialylated and non-sialylated terminal N-acetyllactosamine units on surface-bound extended glycans.
Leppänen A; Stowell S; Blixt O; Cummings RD
J Biol Chem; 2005 Feb; 280(7):5549-62. PubMed ID: 15556936
[TBL] [Abstract][Full Text] [Related]
13. Engineering host cell lines to reduce terminal sialylation of secreted antibodies.
Naso MF; Tam SH; Scallon BJ; Raju TS
MAbs; 2010; 2(5):519-27. PubMed ID: 20716959
[TBL] [Abstract][Full Text] [Related]
14. Altered O-glycosylation and sulfation of airway mucins associated with cystic fibrosis.
Xia B; Royall JA; Damera G; Sachdev GP; Cummings RD
Glycobiology; 2005 Aug; 15(8):747-75. PubMed ID: 15994837
[TBL] [Abstract][Full Text] [Related]
15. The interplay of protein engineering and glycoengineering to fine-tune antibody glycosylation and its impact on effector functions.
Wang Q; Wang T; Zhang R; Yang S; McFarland KS; Chung CY; Jia H; Wang LX; Cipollo JF; Betenbaugh MJ
Biotechnol Bioeng; 2022 Jan; 119(1):102-117. PubMed ID: 34647616
[TBL] [Abstract][Full Text] [Related]
16. Engineering nucleotide sugar synthesis pathways for independent and simultaneous modulation of N-glycan galactosylation and fucosylation in CHO cells.
Prabhu A; Shanmugam D; Gadgil M
Metab Eng; 2022 Nov; 74():61-71. PubMed ID: 36152932
[TBL] [Abstract][Full Text] [Related]
17. Sialylated O-glycans and sulfated tyrosines in the NH2-terminal domain of CC chemokine receptor 5 contribute to high affinity binding of chemokines.
Bannert N; Craig S; Farzan M; Sogah D; Santo NV; Choe H; Sodroski J
J Exp Med; 2001 Dec; 194(11):1661-73. PubMed ID: 11733580
[TBL] [Abstract][Full Text] [Related]
18. A Panel of Recombinant Mucins Carrying a Repertoire of Sialylated O-Glycans Based on Different Core Chains for Studies of Glycan Binding Proteins.
Cherian RM; Jin C; Liu J; Karlsson NG; Holgersson J
Biomolecules; 2015 Aug; 5(3):1810-31. PubMed ID: 26274979
[TBL] [Abstract][Full Text] [Related]
19. The N-glycan profile in cortex and hippocampus is altered in Alzheimer disease.
Gaunitz S; Tjernberg LO; Schedin-Weiss S
J Neurochem; 2021 Oct; 159(2):292-304. PubMed ID: 32986846
[TBL] [Abstract][Full Text] [Related]
20. Cross validation of liquid chromatography-mass spectrometry and lectin array for monitoring glycosylation in fed-batch glycoprotein production.
Hayes CA; Doohan R; Kirkley D; Leister K; Harhen B; Savage AV; Karlsson NG
Mol Biotechnol; 2012 Jul; 51(3):272-82. PubMed ID: 22048797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
